RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Sariol, Carlos A.
One or more keywords matched the following items that are connected to
Sariol, Carlos A.
Item Type
Name
Academic Article
An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.
Academic Article
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
Academic Article
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.
Academic Article
A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.
Academic Article
Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus.
Academic Article
A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?
Academic Article
Time elapsed between Zika and dengue virus infections affects antibody and T cell responses.
Concept
Antibodies, Neutralizing
Academic Article
Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination.
Academic Article
Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.
Academic Article
Limited Impact of Delta Variant's Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population.
Academic Article
Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose.
Academic Article
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity.
Academic Article
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine.
Search Criteria
Antibodies Neutralizing